“Securing FDA clearance for the Follow-Me™ software is a major milestone for MST, making AutoLap® the only market-approved image-based system with image-guided functions for various minimally invasive laparoscopic procedures,” said Motti Frimer, CEO of MST. “We are already commercializing AutoLap® with the Follow Me™ software in Europe, and we now look forward to expanding marketing and sales of the surgeon-focused system in the U.S. in 2016.”